No black box warning on record for Rosuvastatin Calcium

As of the latest FDA labeling reviewed, Rosuvastatin Calcium (ROSUVASTATIN CALCIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Rosuvastatin Calcium medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Myopathy and Rhabdomyolysis : Risk factors include age 65 years or greater, uncontrolled hypothyroidism, renal impairment, concomitant use with certain other drugs, and higher rosuvastatin dosage. Asian patients may be at higher risk for myopathy. Discontinue rosuvastatin if markedly elevated CK levels occur or myopathy is diagnosed or suspected. Temporarily discontinue

No black box warning on record for Rosuvastatin Calcium

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Myopathy and Rhabdomyolysis : Risk factors include age 65 years or greater, uncontrolled hypothyroidism, renal impairment, concomitant use with certain other drugs, and higher rosuvastatin dosage. Asian patients may be at higher risk for myopathy. Discontinue rosuvastatin if markedly elevated CK levels occur or myopathy is diagnosed or suspected. Temporarily discontinue

Rosuvastatin Calcium Black Box Warning

No black box warning on record for Rosuvastatin Calcium

Other warnings & precautions

Rosuvastatin Calcium Black Box Warning

No black box warning on record for Rosuvastatin Calcium

Other warnings & precautions